(lp0
S'Brokers Release Average Price Target Of 9.36 On NeoGenomics, Inc.  UK Market News - Feb 22, 2017 According to the most recent research notes issued by analysts 10 analysts have outstanding research reports on NeoGenomics, Inc. , whilst 5 of which rate the stock Buy, 5 Outperform, 0 Underperform, 0 Sell, while 0 Hold. The latest ...'
p1
aS'NeoGenomics Completes Acquisition of Clarient, Inc. PR Newswire  - Dec 30, 2015 30, 2015 /PRNewswire/ -- NeoGenomics, Inc. , a leading provider of cancer-focused genetic testing services, announced today that it has completed the acquisition of Clarient, Inc. and its wholly-owned subsidiary Clarient Diagnostic ...'
p2
aS'NeoGenomics Schedules its Q1 2017 Earnings Release for April 26, 2017 Stockhouse - Apr 14, 2017 FT. MYERS, FL -- - NeoGenomics, Inc.  announced today that it plans to release its first quarter 2017 financial results on Wednesday, April 26, 2017.'
p3
aS'NeoGenomics signs Definitive Agreement to acquire Clarient, Inc. PR Newswire  - Oct 21, 2015 FORT MYERS, Fla., Oct. 21, 2015 /PRNewswire/ -- NeoGenomics, Inc. , a leading provider of cancer-focused genetic testing services, announced today that it has reached an agreement to acquire Clarient, Inc., and its wholly-owned&nbsp;...'
p4
aS'Analyst Target Update &amp; Review on NeoGenomics, Inc.  Rockville Register - 12 hours ago NeoGenomics, Inc.  shares traded +3.36% during the most recent session. Wall Street analysts covering the stock are projecting that the stock will reach $11.06 within the next 52-weeks.'
p5
aS'Why Neogenomics Inc is Soaring Higher Today Motley Fool - Oct 21, 2015 What: Shares of Neogenomics , a cancer-focused provider of genetic and molecular testing services for hospitals, pathologists, and oncologists, were up more than 20% in trading today after the company announced that it is acquiring Clarient ...NeoGenomics to Acquire GE Cancer Testing Unit Clarient - Wall Street JournalForm 8-K NEOGENOMICS INC For: Oct 21 - StreetInsider.com'
p6
aS'NeoGenomics up on mixed results The News-Press - Mar 1, 2016 Fort Myers-based NeoGenomics Inc. on Tuesday reported a fourth-quarter loss of $1.6 million, after reporting a profit in the same period a year earlier.'
p7
aS'NeoGenomics Inc.  Moves Lower on Volume Spike for April 05 Equities.com - Apr 5, 2017 NeoGenomics Inc.  traded on unusually high volume on Apr. 05, as the stock lost 1.61% to close at $7.65. On the day, NeoGenomics Inc. saw 553,987 shares trade hands on 3,097 trades. Considering that the stock averages only a daily volume of&nbsp;...'
p8
aS"Margins Are Key For NeoGenomics In Q2 2016 Seeking Alpha - Jul 25, 2016 NeoGenomics  is set to release its 2Q'16 earnings report Tuesday morning July 26, 2016. NEO made a huge splash in the Cancer diagnostic world last year when it acquired Clarient."
p9
aS'NeoGenomics: The Cancer Diagnostics Company No One Seems To Be Talking About Seeking Alpha - Apr 27, 2016 For example, OPKO Health  has Dr. Frost, Cancer Genetics Inc.  has John Pappajohn and TrovaGene  has the only cancer monitoring system that can be assessed through urine.'
p10
a.